Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anna K. Fischer"'
Autor:
Dominik Dannehl, Tobias Engler, Lea L. Volmer, Annette Staebler, Anna K. Fischer, Martin Weiss, Markus Hahn, Christina B. Walter, Eva-Maria Grischke, Falko Fend, Florin-Andrei Taran, Sara Y. Brucker, Andreas D. Hartkopf
Publikováno v:
Cancers, Vol 14, Iss 21, p 5365 (2022)
Background: Patients with hormone receptor-positive (HR+), HER2-negative (HER2−) early breast cancer (eBC) with a high risk of relapse often undergo adjuvant chemotherapy. However, only a few patients will gain benefit from chemotherapy. Since clas
Externí odkaz:
https://doaj.org/article/80f0271338674847bbda4b6357a63e51
Autor:
Rebekka Wiedenhoefer, Elisa Schmoeckel, Marcel Grube, Mihály Sulyok, Iana Pasternak, Christine Beschorner, Karen Greif, Sara Brucker, Doris Mayr, Stefan Kommoss, Falko Fend, Annette Staebler, Anna K. Fischer
Publikováno v:
American Journal of Surgical Pathology. 47:558-567
Autor:
Dominik, Dannehl, Tobias, Engler, Lea L, Volmer, Annette, Staebler, Anna K, Fischer, Martin, Weiss, Markus, Hahn, Christina B, Walter, Eva-Maria, Grischke, Falko, Fend, Florin-Andrei, Taran, Sara Y, Brucker, Andreas D, Hartkopf
Publikováno v:
Cancers. 14(21)
Patients with hormone receptor-positive (HR+), HER2-negative (HER2-) early breast cancer (eBC) with a high risk of relapse often undergo adjuvant chemotherapy. However, only a few patients will gain benefit from chemotherapy. Since classical tumor ch
Publikováno v:
Pediatric Nephrology (Berlin, Germany)
Publikováno v:
Pediatric Nephrology (Berlin, Germany)